# Trade Mark Journal No.2025/033 15 August 2025

## WO0000001856135 (5)

Office of origin: United States of America

Date of International Registration:5 April 2025
Date of designation in the UK: 5 April 2025

International priority date claimed: 10 October 2024 (United States of America) (98794121)

Class 5
  Pharmaceutical preparations for immune-mediated inflammatory diseases; biologics for immune-mediated inflammatory diseases.

Prometheus Laboratories, Inc.

Representative: Kelley B. Harrington Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700,, IP Docketing Department, Washington DC 20004, UNITED STATES OF AMERICA